Cutaneous T-Cell Lymphoma in Adults

We diagnose cutaneous T-cell lymphoma, cancer of the white blood cells found in the skin, and provide personalized treatments based on the latest scientific research. Our oncologists, hematologists, and dermatologists work together to provide you with ongoing care and monitoring. Integrative medicine specialists, psycho-oncologists, and social workers are also available to provide the support you need while managing this condition.

Clinical Trials and Research Studies

Phase 5

A Phase 1-2 First-in-Human Study of CX-2029 in Adults with Metastatic or Locally Advanced Unresectable Solid Tumors or Lymphomas.

Learn More

Phase 3

A phase 3 randomized trial for patients with de novo AML comparing standard therapy including gemtuzumab ozogamicin GO to CPX-351 with GO and the addition of the FLT3 inhibitor gilteritinib for patients with FLT3 mutations

Learn More

Phase 2

A Phase II Study of Talimogene laherparepvec Followed by Talimogene laherparepvec + Nivolumab in Refractory T Cell and NK Cell Lymphomas Cutaneous Squamous Cell Carcinoma Merkel Cell Carcinoma and Other Rare Skin Tumors

Learn More

Phase 2

AAML18P1: Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP)

Learn More